|
|
|
| 
|
|
|
My Recent Searches
|
|
|
|
|
|
|
|
|
Ra Pharmaceuticals, Inc. (RARX) |
|
|
$46.96 0.00 (0.00%) as of 4:30 Thu 3/19
|
|
Download |
|
|
| |
| |
| Exchange: |
N/A |
| Security
Type: |
N/A |
| Shares
Out: |
47,150,000 |
| Market
Cap: |
2.21(B) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$46.96 - $46.96 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-01-28 |
2023-10-27 |
2023-04-28 |
2022-04-28 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  King John C |
Chief Commercial Officer |
• – – |
2020-04-02 |
4 |
D |
$48.00 |
$519,504 |
D/D |
(10,823) |
0 |
|
- |
|
| Shah Rajeev M. |
Director |
– • • |
2020-04-02 |
4 |
D |
$48.00 |
$233,196,480 |
I/I |
(4,858,260) |
0 |
|
- |
|
| Ricardo Alonso |
See Remarks |
• – – |
2020-04-02 |
4 |
D |
$48.00 |
$142,704 |
D/D |
(2,973) |
0 |
|
- |
|
| Lubner David Charles |
Executive VP and CFO |
• – – |
2020-04-02 |
4 |
D |
$48.00 |
$749,856 |
D/D |
(15,622) |
0 |
|
- |
|
| Farzaneh-Far Ramin |
Chief Medical Officer |
• – – |
2020-04-02 |
4 |
D |
$48.00 |
$695,616 |
D/D |
(14,492) |
0 |
|
- |
|
| Sandell Scott D |
10% Owner |
– – • |
2020-04-02 |
4 |
D |
$0.00 |
$0 |
D/D |
(6,135,234) |
0 |
|
- |
|
| Treco Douglas A |
President and CEO |
• • – |
2020-04-02 |
4 |
D |
$48.00 |
$11,265,936 |
D/D |
(234,707) |
0 |
|
- |
|
| Kolchinsky Peter |
Director |
– • • |
2020-04-02 |
4 |
D |
$48.00 |
$233,196,480 |
I/I |
(4,858,260) |
0 |
|
- |
|
| Read Simon |
Chief Scientific Officer |
• – – |
2020-04-02 |
4 |
D |
$48.00 |
$604,560 |
D/D |
(12,595) |
0 |
|
- |
|
| Ricardo Alonso |
See Remarks |
• – – |
2020-03-17 |
4 |
AS |
$44.25 |
$101,244 |
D/D |
(2,288) |
0 |
|
5% |
|
| Farzaneh-Far Ramin |
Chief Medical Officer |
• – – |
2020-03-16 |
4 |
AS |
$45.16 |
$478,521 |
D/D |
(10,595) |
7,132 |
|
6% |
|
| Farzaneh-Far Ramin |
Chief Medical Officer |
• – – |
2020-03-16 |
4 |
OE |
$5.60 |
$59,332 |
D/D |
10,595 |
17,727 |
|
- |
|
| Farzaneh-Far Ramin |
Chief Medical Officer |
• – – |
2020-02-18 |
4 |
AS |
$46.61 |
$493,850 |
D/D |
(10,595) |
7,132 |
|
0% |
|
| Farzaneh-Far Ramin |
Chief Medical Officer |
• – – |
2020-02-18 |
4 |
OE |
$5.60 |
$59,332 |
D/D |
10,595 |
17,727 |
|
- |
|
| Ricardo Alonso |
See Remarks |
• – – |
2020-01-17 |
4 |
AS |
$47.02 |
$107,441 |
D/D |
(2,285) |
2,288 |
|
-0% |
|
| Farzaneh-Far Ramin |
Chief Medical Officer |
• – – |
2020-01-15 |
4 |
AS |
$46.95 |
$497,441 |
D/D |
(10,595) |
7,132 |
|
-0% |
|
| Farzaneh-Far Ramin |
Chief Medical Officer |
• – – |
2020-01-15 |
4 |
OE |
$5.60 |
$59,332 |
D/D |
10,595 |
17,727 |
|
- |
|
| Ricardo Alonso |
See Remarks |
• – – |
2019-12-17 |
4 |
AS |
$47.08 |
$107,568 |
D/D |
(2,285) |
4,573 |
|
- |
|
| Read Simon |
Chief Scientific Officer |
• – – |
2019-12-17 |
4 |
AS |
$47.08 |
$470,821 |
D/D |
(10,000) |
6,234 |
|
- |
|
| Read Simon |
Chief Scientific Officer |
• – – |
2019-12-17 |
4 |
OE |
$2.87 |
$28,700 |
D/D |
10,000 |
16,234 |
|
- |
|
| Farzaneh-Far Ramin |
Chief Medical Officer |
• – – |
2019-12-16 |
4 |
AS |
$47.23 |
$500,351 |
D/D |
(10,595) |
7,132 |
|
- |
|
| Farzaneh-Far Ramin |
Chief Medical Officer |
• – – |
2019-12-16 |
4 |
OE |
$5.60 |
$59,332 |
D/D |
10,595 |
17,727 |
|
- |
|
| Farzaneh-Far Ramin |
Chief Medical Officer |
• – – |
2019-11-15 |
4 |
AS |
$46.66 |
$494,319 |
D/D |
(10,595) |
7,132 |
|
- |
|
| Farzaneh-Far Ramin |
Chief Medical Officer |
• – – |
2019-11-15 |
4 |
OE |
$5.60 |
$59,332 |
D/D |
10,595 |
17,727 |
|
- |
|
| Read Simon |
Chief Scientific Officer |
• – – |
2019-11-14 |
4 |
AS |
$46.68 |
$466,808 |
D/D |
(10,000) |
6,234 |
|
- |
|
148 Records found
|
|
Page 1 of 6 |
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
| |
OE |
- Options Exercised |
A |
- Acquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
